Aelin Therapeutics

Foundation date

06/12/2017

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Aelin Therapeutics is a biopharmaceutical company that has secured a 27 M€ investment to pioneer
peptide-based novel modalities to create a powerful first-in-class antibiotics and agents against high value undruggable human targets. 

Upcoming events

Latest news

  • Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks

    Monday March 20th 2023

  • VIB launches Data Core to support life sciences research

    Thursday March 16th 2023

  • Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease

    Thursday March 16th 2023